カテゴリ： MarketLine, アメリカ, 企業調査

National Life Group：企業の戦略・SWOT・財務情報

◆英語タイトル：National Life Group - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C11881
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：34
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

National Life Group – Strategy, SWOT and Corporate Finance Report
Summary

National Life Group – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

National Life Group (National Life) is a life insurance company. It offers a wide range of life insurance, annuity and mutual funds to individuals and families; business owners, schools and public services; and financial professionals. It also offers investment advisory services related to estate, business succession and retirement planning, deferred compensation and executive benefit plans, asset management and administrative services. National Life’s insurance and annuity products are marketed and distributed through general agents and independent brokers. The company operates through its subsidiaries, including National Life Insurance Company and Life Insurance Company of the Southwest. National Life is headquartered in Montpelier, Vermont, the US.

The company reported insurance premium of US$218.4 million for the fiscal year ended December 2016 (FY2016), a decrease of 4% over FY2015.

Scope

- Detailed information on National Life Group required for business and competitor intelligence needs
- A study of the major internal and external factors affecting National Life Group in the form of a SWOT analysis
- An in-depth view of the business model of National Life Group including a breakdown and examination of key business segments
- Intelligence on National Life Group’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about National Life Group, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of National Life Group and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess National Life Group as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on National Life Group’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
National Life Group: Company Overview 9
National Life Group: Overview and Key Facts 9
National Life Group: Overview 9
National Life Group: Key Facts 9
National Life Group: Key Employees 10
National Life Group: Key Employee Biographies 12
National Life Group: Major Products and Services 14
National Life Group: Company History 15
National Life Group: Management Statement 17
National Life Group: Locations and Subsidiaries 19
National Life Group: Key Competitors 20
National Life Group: Company Analysis 21
National Life Group: Business Description 21
National Life Group: SWOT Analysis 22
National Life Group: SWOT Overview 22
National Life Group: Strengths 22
National Life Group: Weaknesses 23
National Life Group: Opportunities 23
National Life Group: Threats 23
National Life Group: Corporate Financial Deals Activity 25
National Life Group: Financial Deals Overview 25
National Life Group: Top Deals 2014 – 2018YTD* 27
National Life Group: Recent Developments 28
National Life Group: News and Events Summary 28
National Life Group: Business Expansion 29
National Life Group: Corporate Governance 29
National Life Group: Strategy and Operations 30
Appendix 32
Contact Us 32
Methodology 32
About MarketLine 33

List of Tables
Table 1: National Life Group: Key Facts
Table 2: National Life Group: Key Employees
Table 3: National Life Group: Company History
Table 4: National Life Group: Locations and Subsidiaries
Table 5: National Life Group: Key Competitors
Table 6: National Life Group: Deal Activity by Deal Type - Volume (TTM*)
Table 7: National Life Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: National Life Group: Top Deals 2014 - 2018YTD*
Table 9: National Life Group: News and Events Summary
Table 10: National Life Group: Business Expansion
Table 11: National Life Group: Corporate Governance
Table 12: National Life Group: Strategy and Operations

List of Figures
Figure 1: National Life Group: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: National Life Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)

★海外企業調査レポート[National Life Group：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Vitae Pharmaceuticals Inc (VTAE)-製薬・医療分野：企業M&A・提携分析
    Summary Vitae Pharmaceuticals Inc (Vitae Pharmaceuticals) is a biopharmaceutical company that offers pharmaceutical products. The company discovers and develops and small molecule drugs for diseases with significant unmet medical needs. Its products pipeline includes VTP-34072, BI 1147560, VTP-43742 …
  • Moximed Inc：医療機器：M&Aディール及び事業提携情報
    Summary Moximed Inc (Moximed), formerly ExploraMed NC4, Inc. focuses to develop unicompartmental load absorber implants for patients with painful knee osteoarthritis (OA). The company provides Atlas Knee System, an implantable knee joint unloader which works as a shock absorber for pre-arthroplasty …
  • Sonoma Pharmaceuticals Inc (OCLS)：企業の財務・戦略的SWOT分析
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • OpGen Inc (OPGN)-製薬・医療分野：企業M&A・提携分析
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • Invesco Ltd：戦略・SWOT・企業財務分析
    Invesco Ltd - Strategy, SWOT and Corporate Finance Report Summary Invesco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Thomas Cook Group plc (TCG)：企業の財務・戦略的SWOT分析
    Thomas Cook Group plc (TCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • KCC Corp (002380)：企業の財務・戦略的SWOT分析
    KCC Corp (002380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aprecia Pharmaceuticals Company：製薬・医療：M&Aディール及び事業提携情報
    Summary Aprecia Pharmaceuticals Company (Aprecia) is a drug delivery technology platform company that develops pharmaceutical drug products. The company offers Zipdose technology, a delivery platform that serves as the foundation of orodispersible formulations of prescribed high-dose medications. It …
  • China National Nuclear Power Co Ltd (601985)：電力：M&Aディール及び事業提携情報
    Summary China National Nuclear Power Co Ltd (CNNPC), a subsidiary of China National Nuclear Corp is a nuclear energy company. The company provides activities such as development, investment, construction, operations and management of nuclear power projects and technical research in the safe operatio …
  • China Telecom Corporation Limited：企業の戦略・SWOT・財務分析
    China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • The British United Provident Association Limited ：企業の戦略・SWOT・財務情報
    The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report Summary The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Syneos Health Inc：企業の戦略・SWOT・財務分析
    Syneos Health Inc - Strategy, SWOT and Corporate Finance Report Summary Syneos Health Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Gordon Food Service Inc：企業の戦略的SWOT分析
    Gordon Food Service Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • OKD as：企業の戦略・SWOT・財務情報
    OKD as - Strategy, SWOT and Corporate Finance Report Summary OKD as - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • PowerFilm, Inc.：企業の戦略的SWOT分析
    PowerFilm, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • APEIRON Biologics AG：製薬・医療：M&Aディール及び事業提携情報
    Summary APEIRON Biologics AG (APEIRON) is a clinical-stage biotechnology company that concentrates on the development of biological and immunological solutions for the treatment of various cancers. The company’s pipeline products include APN01, APN301, APN311, APN401, APN411, APN421 and APN431. Its …
  • Chugai Pharmaceutical Co Ltd (4519)-製薬・医療分野：企業M&A・提携分析
    Summary Chugai Pharmaceutical Co Ltd (Chugai), a subsidiary of Hoffmann-La Roche Ltd, is a provider of biopharmaceuticals and therapeutic antibodies. The company offers products for the treatment of cancer; bone and joint diseases; renal diseases; immunology and infectious diseases and others. It al …
  • The Arag Group
    The Arag Group - Strategy, SWOT and Corporate Finance Report Summary The Arag Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • BioPorto Diagnostics AS：医療機器：M&Aディール及び事業提携情報
    Summary BioPorto Diagnostics AS (BioPorto Diagnostics), formerly AntibodyShop AS is an in-vitro diagnostics company that manufactures and markets antibodies and antibody based products. The company’s products include matched reagent set, immunoassays, antigens, antibodies, controls calibrators and m …
  • Advanced Biological Laboratories SA-製薬・医療分野：企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆